Navigation Links
GW Cancer Institute receives $100,000 for patient navigator from the Avon Foundation
Date:5/6/2014

WASHINGTON (May 6, 2014) The Avon Foundation announced a $100,000 grant to The George Washington University (GW) Cancer Institute at the 12th annual Avon Walk for Breast Cancer in Washington, D.C.

Eloise Caggiano, a breast cancer survivor and Avon Walk for Breast Cancer program director, announced eight new grants to local breast cancer organizations, ensuring the funds raised immediately benefit the local community. "These grants represent only a portion of the funding that the Avon Foundation will distribute in the Washington, D.C. area and across the country this year, but we want to make sure the impact of your Walk begins today. Every grant moves us closer toward our goal of a world without breast cancer," said Caggiano.

A $100,000 check was presented to Mandi Pratt-Chapman, M.A., director of the GW Cancer Institute, to support an Avon patient navigator. The patient navigator will remove barriers and coordinate access to care for prompt diagnosis, and assist with insurance access and resources for more than 1,000 patients.

"We are so pleased to continue our partnership with the Avon Foundation to help vulnerable patients obtain timely diagnosis and follow up care," said Pratt-Chapman, principal investigator for the award. "Through Avon's support, we are supporting patients at the local level and applying what we learn to develop standards for patient navigation regionally and nationally."

The Avon Walk Washington, D.C. the second of eight 2014 Avon Walks across the country attracted 2,000 participants from 42 states and D.C., as well as Canada, Bulgaria and Puerto Rico. In addition, 260 breast cancer survivors and 285 men joined together to raise lifesaving funds for breast cancer.


'/>"/>

Contact: Lisa Anderson
lisama2@gwu.edu
202-994-3121
George Washington University
Source:Eurekalert

Page: 1

Related medicine news :

1. Study Suggests Vaccine May Help Kids With Brain Cancer
2. New Stool Test Might Aid in Early Detection of Colon Cancer
3. Study reveals how cancer drug causes diabetic-like state
4. How a cancer drug leads to diabetes
5. You Survived Cancer: Now Pay Attention to Your Overall Health
6. New drug prevents spread of human prostate cancer cells
7. Eliminating the good cholesterol receptor may fight breast cancer
8. Taller, Heavier Women May Face Higher Ovarian Cancer Risk
9. Experimental Chemo Combo for Colon Cancer Disappoints
10. Veggies Like Broccoli, Cabbage May Help Fight Breast Cancer: Study
11. Targeted therapeutics for colon cancer to be presented at AACR meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... ... March 28, 2017 , ... Z-Medica, ... University of Pittsburgh Medical Center (UPMC) will acquire QuikClot® Bleeding Control Kits® (BCK) ... program, developed in association with efforts by the American College of Surgeons, U.S. ...
(Date:3/28/2017)... (PRWEB) , ... March 28, 2017 , ... ... laboratory instruments are critical to ensuring high-quality results and maintaining GMP and USP ... of Laboratory Instruments in accordance with GMP requirements " these requirements are explained. ...
(Date:3/28/2017)... ... 28, 2017 , ... With less than 10,000 dermatologists in the United States ... be limited while the desire to conquer breakouts and eliminate skincare stress is widespread. ... customer online, today released its inaugural survey on the State of Acne in America. ...
(Date:3/28/2017)... ... , ... Columbus OH. Dr. Justin Harper, Founder of Juvly Aesthetics in Ohio ... country to sit on the 2017 National Advisory Board for Allergan’s Facial Aesthetics National ... helped propel the clinic from a small start-up to number 78 in the country ...
(Date:3/28/2017)... ... March 28, 2017 , ... Public relations pros work hard to ... of business channels. , While many results are clear, much of PR is hard ... , When it comes to measurement, firms should always take an all-inclusive approach that ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... Israel , March 28, 2017 Emosis ... This new business entity, Emosis Ltd, headquartered in Tel ... of novel assays complementing the mother company existing technology platform and ... and sales development of Emosis kits. ... This strategic move starts building Emosis international footprint. ...
(Date:3/28/2017)... 2017  AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a ... commercialization of innovative therapies for the treatment of ... Agency (EMA) has notified the company that the ... Application (MAA) has passed validation, and that the ... MAA for ARX-04 (known as DSUVIA™ in the ...
(Date:3/28/2017)... Mass. , March 28, 2017 ... company developing innovative therapeutics that address significant unmet ... a patent from the Japan Patent Office (JPO) ... connective tissue growth factor (CTGF) for the treatment ... limited to skin fibrosis and proliferative retinopathy (Japanese ...
Breaking Medicine Technology: